Verify compliant replacement parts for aging systems by requiring written evidence: the part number and revision, the producer’s identity, the applicable standard the item was made to, and the batch record. Then re-test the device after fitting, and record a risk assessment for any non-OEM item against the device’s own specification.

Why Aging Systems Are the Hard Case

An in-support device has a reference point: the manufacturer’s own part list, its service documentation, and its technical support. An aging device loses all three gradually, and the order in which they disappear determines how difficult sourcing becomes.

• The part is discontinued while the device remains in clinical use.
• The manufacturer’s documentation is no longer maintained or updated.
• Field notices stop being issued for the model, so known issues are no longer communicated.
• The service route closes, leaving in-house engineering or third-party providers.
• Compatible and third-party items become the only available supply.
• The device continues in service beyond the point at which its documentation stopped moving.

The consequence is that the buyer carries the judgement the manufacturer used to carry. That is not impossible to do well, but it requires a different process, one built on documented evidence rather than on a part number being available from a familiar source.

What ‘Compliant’ Has to Mean Here

In this context, compliant cannot mean that the item carries the original manufacturer’s name, because that route may no longer exist. It has to mean something a buyer can test: that the item meets the specification the device requires, that its provenance is documented, and that its use has been assessed against the risk the device presents.

The rows narrow as they descend, and the fourth is where most real sourcing decisions sit. Functionally equivalent items can be an appropriate answer for an aging system, but only where the practice has defined what performance has to be demonstrated and has a way of testing it. The fifth row is not a compliance position at all, because there is nothing to verify.

Documentation a Supplier Should Provide

The documentation to request is the same list for every supplier, and requesting it in writing is what makes the comparison possible. A supplier that provides it is describing what it sells; a supplier that cannot is asking to be taken on trust.

• The part number and revision, stated rather than implied.
• The producer of the item, named rather than alluded to.
• The specification or standard the item was made to, where one applies.
• Material, dimensions, or performance data where those are the basis of equivalence.
• Batch or lot identification for the items supplied.
• A statement of whether the item is new, refurbished, or removed from a decommissioned device.
• Any restriction the supplier places on use, including devices it should not be fitted to.
• The supplier’s warranty position and returns terms.

The seventh item is the one most often omitted and the one that most affects risk. A supplier willing to state which devices an item should not be fitted to is describing the limits of its own product, which is a materially different position from a supplier that presents every item as universally suitable.

Traceability From Batch to Fitting

Traceability has to run in both directions to be useful: from the batch back to the producer, and from the batch forward to the device it was fitted to. A record that supports only one direction cannot answer the question that matters after an incident, which is which devices received the affected items.

The last row is what a recall or a field notice actually requires. Without it, a batch problem becomes an exercise in reconstructing history from invoices, which is slower and less reliable than reading it from a register. Where the same item is fitted across several devices, the register should be structured so that a single batch reference returns all of them.

Electrical Safety and Performance Re-Testing

Fitting a part changes the device, so the verification performed after fitting is part of the sourcing process rather than an optional extra. The scope should be proportionate to what the part affects, and it should be defined before the repair rather than improvised afterwards.

• Electrical safety testing, anchored to the IEC 60601 series in most clinical service programs.
• Performance testing of the function the replaced part supports, measured rather than observed.
• Calibration where the device’s documentation specifies a step after the assembly is changed.
• A check of the functions adjacent to the repair, since failures are frequently found in neighboring assemblies.
• Review of any device log or self-test output produced after the repair.
• Confirmation that the device’s software recognizes the fitted assembly, where it reports one.
• A return-to-service decision recorded with the reasoning, not only the result.

The second item is where rigor is most often lost on aging systems, because measuring performance requires a reference value and an instrument. Where the original specification has to be reconstructed from the device’s historical records, that reconstruction belongs in the file as the basis for the acceptance decision rather than remaining an assumption held by an engineer.

Risk Assessment for Non-OEM Parts

A non-OEM part is a risk decision rather than a purchasing shortcut, and the risk should be assessed and written down before the part is fitted rather than reviewed after something goes wrong. The assessment does not need to be elaborate; it needs to be specific.

• What function the part performs, and what happens if it fails or performs outside specification.
• Whether the function is safety-related, and to whom.
• What evidence supports the claimed equivalence, and how directly it maps to the device.
• Whether the failure mode is detectable before clinical use, or only in use.
• What the consequence of an undetected failure would be.
• Whether the alternative of replacing the device is available and proportionate.
• Who accepted the risk, and on what date.

The fourth and sixth items are the ones that decide most cases. Where a failure would be detected during the post-fitting test, the risk is contained and the item is usually acceptable. Where a failure would only appear in clinical use, and the device’s remaining service life is short, the money is better directed at replacement. Regulatory references for the market the device operates in should be checked rather than assumed, with the FDA medical device portal and the electronic Code of Federal Regulations covering the United States and EUR-Lex the EU position including MDR 2017/745.

When the Correct Answer Is Replace, Not Repair

Some aging systems reach a point where parts compliance is the wrong question, because the cost and uncertainty of continuing outweigh the value the device still returns. Recognizing that point is part of maintaining the equipment, not an admission of defeat.

The last row is the clearest indicator, and it is cumulative rather than sudden. A single accepted risk on an aging device is normal engineering practice. A growing file of them, each accepted because the alternative is a capital purchase, means the device is consuming management attention as well as maintenance budget, and that cost belongs in the comparison.

Records for Inspection and Audit

The records that support parts compliance are the same records an inspection asks for, which is one of the few places where regulatory and operational needs align exactly. Keeping them against the device rather than against the transaction is what makes retrieval practical.

• Device identification, including the model, serial number, and in-service date.
• The maintenance schedule applied, and the basis on which it was set.
• Parts fitted, with batch or lot identification and the supplier’s documentation attached.
• Test and calibration results after each intervention, with the reference values used.
• Risk assessments accepted for non-OEM parts, with the decision and the date.
• Any outstanding action left open at the time of the record.
• Confirmation that the device’s support position has been reviewed since the last record.

Before signing or paying for a part, verify:

• That the item’s specification and the evidence of equivalence are in writing.
• That the producer is named, and the batch identification will be supplied.
• That the supplier has stated any device the item should not be fitted to.
• That the item is not presented as something it cannot be evidenced to be.
• That the testing to be performed after fitting is defined, resourced, and referenced to a standard.
• That the risk assessment for a non-OEM item has been completed before fitting, not after.
• That the forward trace from the batch to the device will be recorded.
• That the total commitment, including testing and records, has been considered against replacement.

Maintenance and testing expectations should be measured against recognized practice rather than agreed informally, and bodies such as AAMI publish guidance that service functions use when defining intervals and documentation. Independent safety reporting belongs in the same file, because a notice affecting a model can change both the acceptance position for a part and the device’s continued usability; alert reporting of the kind published by ECRI is the customary source.

Compliance on an aging system is a documented judgement rather than a label on a box. The practice that requires evidence, re-tests after fitting, and records its risk decisions can source through the handpieces, transducers, and consumables category, work with service, repair, and calibration, check the regulatory position under compliance and regulatory, and submit a specification through a quotation request.

Questions About Parts Compliance